Cutaneous Drug Reactions in patients admitted to the Dermatology Unit at the University Hospital of the West Indies, Kingston, Jamaica

West Indian Medical Journal

Volumn 58, Issue 3, 2009, Pages 227-230

  East Innis, A D ^a   Thompson, D S ^a  

^a UNIVERSITY OF THE WEST INDIES   (Jamaica)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIHYPERTENSIVE AGENT; ANTIINFECTIVE AGENT; CARBAMAZEPINE; CEFTRIAXONE; CEFUROXIME; CHLORPROPAMIDE; CLOXACILLIN; COTRIMOXAZOLE; DICLOFENAC; DICLOFENAC POTASSIUM; DIPYRONE; ENALAPRIL; ERYTHROMYCIN; GENTAMICIN; GLIBENCLAMIDE; METFORMIN; METRONIDAZOLE; NIFEDIPINE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PENICILLIN G; PHENYTOIN; ROXITHROMYCIN; SULFONYLUREA; TETRACYCLINE; UNINDEXED DRUG;

ABRASION; ADOLESCENT; ADULT; AGED; ANEMIA; ARTICLE; CHILD; COMORBIDITY; CONJUNCTIVITIS; CONTROLLED STUDY; CORNEA ABRASION; DRUG ERUPTION; ERYTHEMA MULTIFORME; FEMALE; GASTRITIS; GLUCOSE INTOLERANCE; HEMATURIA; HEPATITIS; HISTOPATHOLOGY; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; HYPOKALEMIA; HYPONATREMIA; JAMAICA; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; PANCYTOPENIA; PRESCHOOL CHILD; PROGNOSIS; SCHOOL CHILD; SKIN MANIFESTATION; STEVENS JOHNSON SYNDROME; SYMBLEPHARON; THROMBOCYTOPENIA; TOXIC EPIDERMAL NECROLYSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; COMORBIDITY; DERMATOLOGY; DRUG ERUPTIONS; EPIDERMAL NECROLYSIS, TOXIC; ERYTHEMA MULTIFORME; FEMALE; HOSPITAL DEPARTMENTS; HOSPITALS, UNIVERSITY; HUMANS; JAMAICA; MALE; MIDDLE AGED; PHARMACEUTICAL PREPARATIONS; RETROSPECTIVE STUDIES; RISK FACTORS; STEVENS-JOHNSON SYNDROME; TREATMENT OUTCOME; YOUNG ADULT;

EID: 71949127616     PISSN: 00433144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Bigby M, Jick S, Jick H, Arndt K. Drug-induced cutaneous reactions: a report from the Boston Collaborative Drug Surveillance Program on 15,438 consecutive patients, 1975-1982. JAMA 1986; 256: 3358-3363
2. Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med 1994; 331: 1272-1285 (Pubitemid 24333193)
3. Knowles SR, Shear NH. Recognition and management of severe cutaneous drug reactions. Dermatol Clin 2007; 25: 245-253 (Pubitemid 46550729)
4. Fiszenson-Albala F, Auzerie V, Mahe E, Farinotti R, Durand-Stocco C, Crickx B. A 6-month prospective survey of cutaneous drug reactions in a hospital setting. Br J Dermatol 2003; 149: 1018-1022 (Pubitemid 37541988)
5. Bigby M. Rates of cutaneous reactions to drugs. Arch Dermatol 2001; 137: 765-770
6. Sharma VK. Cutaneous adverse drug reactions: clinical pattern and causal agents. J Postgrad Med 2001; 47: 95-99
7. Sehgal S, Balachandran C, Shenol SD. Clinical study of cutaneous drug reactions in 80 patients. Indian J Dermatol Venereol Leprol 2003; 69: 6-7. (Pubitemid 44943133)
8. Man CB, Kwan P, Baum L, Yu E, Lau KM, Cheng AS, Ng MH. Association between HLA-B* 1502 allele and antiepileptic drug- induced cutaneous reactions in Han Chinese. Epilepsia 2007; 48: 1015-1018 (Pubitemid 46763406)